Causes and Management of Hypervitaminosis A

Primary Causes

Elevated serum vitamin A concentrations arise mainly from excessive intake of pre‑formed retinol, impaired renal clearance in chronic kidney disease (CKD), or use of systemic retinoid medications. American Academy of Dermatology; American Society of Nephrology; Clinical Nutrition Society 1, 2, 3
In CKD, both retinol and retinol‑binding protein (RBP) are normally catabolized in the renal tubules; loss of tubular function leads to their accumulation in the circulation. American Society of Nephrology 2
When glomerular filtration rate declines and tubular activity is compromised, serum vitamin A and RBP concentrations rise markedly. American Society of Nephrology 2
Serum RBP4 concentrations are approximately four‑fold higher in individuals with CKD compared with healthy adults. Clinical Nutrition Society 3
Pediatric patients receiving dialysis without supplemental vitamin A exhibit serum vitamin A levels about three times those of age‑matched controls. American Society of Nephrology 2
Vitamin A is not removed by conventional dialysis modalities, resulting in progressive systemic accumulation. American Society of Nephrology 2
Routine vitamin A supplementation is contraindicated in CKD because of the heightened risk of toxicity. American Society of Nephrology; Clinical Nutrition Society 2, 3

Treatment with acitretin for dermatologic disorders (e.g., psoriasis, ichthyosis, lichen planus) elevates systemic retinoid levels. British Association of Dermatologists; American Academy of Dermatology 4, 1
Co‑administration of vitamin A supplements during acitretin therapy markedly increases the risk of hypervitaminosis A and should be avoided. American Academy of Dermatology 1
Patients on acitretin should limit dietary vitamin A intake to ≤ 2,400–3,000 IU per day (≈ 0.8–1 mg) to reduce toxicity risk. British Association of Dermatologists 4

Serum retinyl ester concentrations > 250 nmol/L are indicative of clinically significant vitamin A excess. Clinical Nutrition Society 5
The liver stores > 90 % of total body vitamin A as retinyl esters within hepatic stellate cells. Clinical Nutrition Society 6
Serum retinol may remain within normal limits despite substantial total‑body vitamin A overload, because retinol reflects stores only when severely depleted or markedly elevated. Clinical Nutrition Society 5
Inflammatory states lower serum retinol by reducing hepatic RBP release, potentially masking hypervitaminosis A. Clinical Nutrition Society 5
In CKD, elevated serum retinol can coexist with depleted hepatic vitamin A reserves, creating diagnostic ambiguity. Clinical Nutrition Society 3
Concurrent protein or zinc deficiency can confound interpretation of serum retinol measurements. Clinical Nutrition Society 5

Adults with CKD stages 3–5 or receiving dialysis require vigilant monitoring and should avoid vitamin A supplementation. American Society of Nephrology; Clinical Nutrition Society 2, 3
Individuals on long‑term acitretin or isotretinoin therapy constitute a high‑risk group for vitamin A toxicity. British Association of Dermatologists; American Academy of Dermatology 4, 1
Patients with diabetes, obesity, or chronic alcohol use have an amplified risk of toxicity when combined with systemic retinoids. British Association of Dermatologists; American Academy of Dermatology 4, 1

Assess serum retinyl ester levels rather than relying solely on serum retinol; values > 250 nmol/L denote toxicity. Clinical Nutrition Society 5
Conduct lipid profile testing monthly for the first three months of retinoid therapy, then every three months thereafter. American Academy of Dermatology 1
Perform regular liver function testing, as hepatotoxicity is a principal adverse effect of excess vitamin A. American Academy of Dermatology 1

The only recognized treatment for vitamin A toxicity is immediate cessation of all vitamin A supplementation and dietary sources, particularly preformed retinol from supplements and animal products 7
Stop all vitamin A supplements immediately upon recognition of toxicity 8, 7
No specific antidote or pharmacological treatment exists for vitamin A toxicity 7
Management is entirely supportive, addressing symptoms as they arise 7
Monitor for acute complications including increased intracranial pressure, nausea, headaches, and bone/joint pain 8

Develops after ingestion of >300,000 IU in adults or >60,000 IU in children within hours to days 8
Symptoms include increased intracranial pressure, severe headache, nausea, vomiting, and musculoskeletal pain 8
Results from daily intake of >25,000 IU for more than 6 years or >100,000 IU for more than 6 months 8, 7
Doses above 14,000 mg/day for prolonged periods cause hepatotoxic effects 8

The upper limit for women of childbearing age is 10,000 IU daily 8, 9
Switch to beta-carotene forms if supplementation is still needed, as it has negative feedback control and lower toxicity risk 10, 11
High retinol serum levels are often observed despite potential total body store depletion in patients with chronic kidney disease 8
Supplementation is not recommended, but regular monitoring is essential in patients with chronic kidney disease 8

Water-miscible and water-soluble forms carry higher toxicity risk than oil-based supplements 10, 12